Please assess the completion status of the following clinical trial:

Trial Title: Using Magnetic Resonance Imaging (MRI) to Guide Differential-Dose Prostate Brachytherapy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical stage ≤ T2b according to the American Joint Commission on Cancer 6th Edition28~* PSA ≤ 15 ng/ml~* Gleason sum on biopsy ≤ 6 or 3+4=7~* Prostate volume ≤ 60 cc~* Willing to continue follow-up for at least two years~Exclusion Criteria:~* Prior hormone therapy~* Prior radiotherapy~* History of collagen vascular disease~* History of inflammatory bowel disease

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Pre-implant MRI images and planning (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).